Pricing Zolgensma – the world’s most expensive drug

Saved in:
Bibliographic Details
Main Author: Mark Nuijten
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:http://dx.doi.org/10.1080/20016689.2021.2022353
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850250262444244992
author Mark Nuijten
author_facet Mark Nuijten
author_sort Mark Nuijten
collection DOAJ
format Article
id doaj-art-8c8c4e03a3ba4254a161e3b85a2e87a0
institution OA Journals
issn 2001-6689
language English
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Journal of Market Access & Health Policy
spelling doaj-art-8c8c4e03a3ba4254a161e3b85a2e87a02025-08-20T01:58:16ZengMDPI AGJournal of Market Access & Health Policy2001-66892022-12-0110110.1080/20016689.2021.20223532022353Pricing Zolgensma – the world’s most expensive drugMark Nuijten0A2Mhttp://dx.doi.org/10.1080/20016689.2021.2022353price valuation reimbursementorphan disease
spellingShingle Mark Nuijten
Pricing Zolgensma – the world’s most expensive drug
Journal of Market Access & Health Policy
price valuation reimbursement
orphan disease
title Pricing Zolgensma – the world’s most expensive drug
title_full Pricing Zolgensma – the world’s most expensive drug
title_fullStr Pricing Zolgensma – the world’s most expensive drug
title_full_unstemmed Pricing Zolgensma – the world’s most expensive drug
title_short Pricing Zolgensma – the world’s most expensive drug
title_sort pricing zolgensma the world s most expensive drug
topic price valuation reimbursement
orphan disease
url http://dx.doi.org/10.1080/20016689.2021.2022353
work_keys_str_mv AT marknuijten pricingzolgensmatheworldsmostexpensivedrug